Andson Biotech Analysis
What is Andson Biotech?
Andson Biotech develops advanced biotools, particularly DynaCHIP, to enhance mass spectrometry workflows for biotherapeutic discovery and manufacturing.
Product Features & Capabilities
- DynaCHIP, 1-second sample preparation, advanced microfluidics, high throughput bioanalytics, dynamic feedback control.
Who are the founders of Andson Biotech
MC
Mason Chilmonczyk
Founder, CEO
Market Focus
Andson Biotech primarily focuses on the biotechnology industry, specializing in advanced biotherapeutics and tools for drug discovery and development, particularly in mass spectrometry workflows.
Business Model
Business model focuses on advanced bioanalytical systems; revenue from product sales and funding.
Investors
- Glenn H. Epstein
- BioTools Innovator
- Y Combinator
- Phase Two Ventures
- Gaingels
- MedTech Innovator
Competitors Overview
Andson Biotech operates in the biotherapeutics and mass spectrometry market, where it faces competition from several notable companies. The main competitors include:
- Agilent Technologies, Inc.
- Overview: A leading player in the mass spectrometry market, Agilent offers a wide range
See something that needs updating? Suggest edits to this profile.